These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 8867293
21. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy. Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA. J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378 [Abstract] [Full Text] [Related]
22. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL, AVID Investigators. J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538 [Abstract] [Full Text] [Related]
23. Potential proarrhythmic effect of biventricular pacing: fact or myth? Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C. Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749 [Abstract] [Full Text] [Related]
24. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation. Kou WH, Kirsh MM, Bolling SF, Stirling M, Kadish AH, De Buitleir M, Calkins H, Lewis RR, Morady F. Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1586-92. PubMed ID: 1721147 [Abstract] [Full Text] [Related]
27. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ. JACC Clin Electrophysiol; 2017 Mar 01; 3(3):243-250. PubMed ID: 29759518 [Abstract] [Full Text] [Related]
28. Electrophysiologic study: its predictive value for ventricular arrhythmias. Gold DR, Catanzaro JN, Makaryus JN, Waldman C, Sauer WH, Sison C, Makaryus AN, Altman E, Jadonath R, Beldner S. Tex Heart Inst J; 2010 Mar 01; 37(3):291-6. PubMed ID: 20548804 [Abstract] [Full Text] [Related]
32. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator. Neglia JJ, Krol RB, Giorgberidze I, Mathew P, Lewis C, Munsif AN, Saksena S. J Interv Card Electrophysiol; 1997 Feb 01; 1(1):49-56. PubMed ID: 9869951 [Abstract] [Full Text] [Related]
36. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator. Wolpert C, Kuschyk J, Aramin N, Spehl S, Streitner F, Süselbeck T, Schumacher B, Haase KK, Schimpf R, Borggrefe M. Heart; 2004 Jun 01; 90(6):667-71. PubMed ID: 15145875 [Abstract] [Full Text] [Related]
37. Evidence rather than costs must guide use of the implantable cardioverter defibrillator. Delacretaz E, Schlaepfer J, Metzger J, Fromer M, Kappenberger L. Am J Cardiol; 2000 Nov 02; 86(9A):52K-57K. PubMed ID: 11084101 [Abstract] [Full Text] [Related]
39. Reduction of antiarrhythmic drug use in patients receiving implantable cardioverter defibrillators. Sperry RE, Stambler BS, Wood MA, Cycan A, Ellenbogen KA. Pacing Clin Electrophysiol; 1996 Jan 02; 19(1):61-4. PubMed ID: 8848378 [Abstract] [Full Text] [Related]